All In Biotech

Drug Trial Radar · NCT03466268

Study to Evaluate the Safety and Anti-tumor Activity of SCC244

A Phase I Trial to Assess the Safety, Pharmacokinetics, and Anti-tumor Activity of SCC244 in Subjects With Advanced Solid Tumors

Last checked: Nov 20, 2026Latest source record: Oct 9, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

56

Actual

Start

Sep 14, 2017

Primary completion

Jan 9, 2023

Study completion Jan 9, 2023

Sponsor

Lead sponsor
Haihe Biopharma Co., Ltd.Industry
Sponsor type
Industry
First posted
Mar 15, 2018

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study evaluates the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of SCC244 in patients with advanced solid tumors with c-Met Alterations.

Conditions

  • Advanced Solid Tumor

Interventions

  • Gumarontinib TabletsDrug

    Either at 100mgSD、100mgQD、200mgSD、200mgQD、400mgSD、400mgQD、300mgBID、400mgBID

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. DLT(Dose limit toxity)Time frame: 35 days
  2. MTD(Max tolerance does)Time frame: 35 days
  3. BED(Biological effective dose)Time frame: 35 days
  4. ORR(Objective response rate)Time frame: 8 weeks

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Guangdong General Hospital

    Guangzhou, Guangzhou, China

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.